Report Detail
COVID-19 Impact on Global Pandemic Influenza Vaccine Market Insights, Forecast to 2026
- RnM4042351 |
- 15 June, 2020 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Pandemic Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pandemic Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pandemic Influenza Vaccine market is segmented into
Influenza A (H1N1) Vaccines
Other
Segment by Application, the Pandemic Influenza Vaccine market is segmented into
Adult
Paediatric
Regional and Country-level Analysis
The Pandemic Influenza Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pandemic Influenza Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pandemic Influenza Vaccine Market Share Analysis
Pandemic Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pandemic Influenza Vaccine business, the date to enter into the Pandemic Influenza Vaccine market, Pandemic Influenza Vaccine product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
Valneva
Lupin
Chiron Panacea
Solvay and Serum Institute of India Pvt. Ltd.
Sementis
1 Study Coverage
- 1.1 Pandemic Influenza Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Pandemic Influenza Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type
- 1.4.2 Influenza A (H1N1) Vaccines
- 1.4.3 Other
- 1.5 Market by Application
- 1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application
- 1.5.2 Adult
- 1.5.3 Paediatric
- 1.6 Coronavirus Disease 2019 (Covid-19): Pandemic Influenza Vaccine Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Pandemic Influenza Vaccine Industry
- 1.6.1.1 Pandemic Influenza Vaccine Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Pandemic Influenza Vaccine Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Pandemic Influenza Vaccine Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Pandemic Influenza Vaccine Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Pandemic Influenza Vaccine Market Size Estimates and Forecasts
- 2.1.1 Global Pandemic Influenza Vaccine Revenue 2015-2026
- 2.1.2 Global Pandemic Influenza Vaccine Sales 2015-2026
- 2.2 Pandemic Influenza Vaccine Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pandemic Influenza Vaccine Competitor Landscape by Players
- 3.1 Pandemic Influenza Vaccine Sales by Manufacturers
- 3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Pandemic Influenza Vaccine Revenue by Manufacturers
- 3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2019
- 3.2.5 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Pandemic Influenza Vaccine Price by Manufacturers
- 3.4 Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Pandemic Influenza Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Pandemic Influenza Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Pandemic Influenza Vaccine Revenue by Type (2015-2020)
- 4.1.3 Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Pandemic Influenza Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Pandemic Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Pandemic Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Pandemic Influenza Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Pandemic Influenza Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Pandemic Influenza Vaccine Revenue by Application (2015-2020)
- 5.1.3 Pandemic Influenza Vaccine Price by Application (2015-2020)
- 5.2 Pandemic Influenza Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Pandemic Influenza Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Pandemic Influenza Vaccine by Country
- 6.1.1 North America Pandemic Influenza Vaccine Sales by Country
- 6.1.2 North America Pandemic Influenza Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Pandemic Influenza Vaccine Market Facts & Figures by Type
- 6.3 North America Pandemic Influenza Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Pandemic Influenza Vaccine by Country
- 7.1.1 Europe Pandemic Influenza Vaccine Sales by Country
- 7.1.2 Europe Pandemic Influenza Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pandemic Influenza Vaccine Market Facts & Figures by Type
- 7.3 Europe Pandemic Influenza Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Pandemic Influenza Vaccine by Region
- 8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region
- 8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Pandemic Influenza Vaccine by Country
- 9.1.1 Latin America Pandemic Influenza Vaccine Sales by Country
- 9.1.2 Latin America Pandemic Influenza Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Pandemic Influenza Vaccine by Country
- 10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country
- 10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Corporation Information
- 11.1.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
- 11.1.5 AstraZeneca Recent Development
- 11.2 GlaxoSmithKline
- 11.2.1 GlaxoSmithKline Corporation Information
- 11.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered
- 11.2.5 GlaxoSmithKline Recent Development
- 11.3 Novartis
- 11.3.1 Novartis Corporation Information
- 11.3.2 Novartis Description, Business Overview and Total Revenue
- 11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Novartis Pandemic Influenza Vaccine Products Offered
- 11.3.5 Novartis Recent Development
- 11.4 Sanofi
- 11.4.1 Sanofi Corporation Information
- 11.4.2 Sanofi Description, Business Overview and Total Revenue
- 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Sanofi Pandemic Influenza Vaccine Products Offered
- 11.4.5 Sanofi Recent Development
- 11.5 Valneva
- 11.5.1 Valneva Corporation Information
- 11.5.2 Valneva Description, Business Overview and Total Revenue
- 11.5.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Valneva Pandemic Influenza Vaccine Products Offered
- 11.5.5 Valneva Recent Development
- 11.6 Lupin
- 11.6.1 Lupin Corporation Information
- 11.6.2 Lupin Description, Business Overview and Total Revenue
- 11.6.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Lupin Pandemic Influenza Vaccine Products Offered
- 11.6.5 Lupin Recent Development
- 11.7 Chiron Panacea
- 11.7.1 Chiron Panacea Corporation Information
- 11.7.2 Chiron Panacea Description, Business Overview and Total Revenue
- 11.7.3 Chiron Panacea Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered
- 11.7.5 Chiron Panacea Recent Development
- 11.8 Solvay and Serum Institute of India Pvt. Ltd.
- 11.8.1 Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
- 11.8.2 Solvay and Serum Institute of India Pvt. Ltd. Description, Business Overview and Total Revenue
- 11.8.3 Solvay and Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered
- 11.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development
- 11.9 Sementis
- 11.9.1 Sementis Corporation Information
- 11.9.2 Sementis Description, Business Overview and Total Revenue
- 11.9.3 Sementis Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Sementis Pandemic Influenza Vaccine Products Offered
- 11.9.5 Sementis Recent Development
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Corporation Information
- 11.1.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
- 11.1.5 AstraZeneca Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Pandemic Influenza Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Pandemic Influenza Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Pandemic Influenza Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pandemic Influenza Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Pandemic Influenza Vaccine. Industry analysis & Market Report on COVID-19 Impact on Global Pandemic Influenza Vaccine is a syndicated market report, published as COVID-19 Impact on Global Pandemic Influenza Vaccine Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Pandemic Influenza Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
